Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
204 hedge funds and large institutions have $2.38B invested in Immunomedics Inc in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 85 increasing their positions, 51 reducing their positions, and 26 closing their positions.
570% more call options, than puts
Call options by funds: $75.3M | Put options by funds: $11.2M
67% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 51
12% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 26
0% more funds holding
Funds holding: 204 → 204 (0)
29% less capital invested
Capital invested by funds: $3.37B → $2.38B (-$992M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$49.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$47.8M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$37.1M |
| 4 |
BlackRock
New York
|
+$18.7M |
| 5 |
DM
Deerfield Management
New York
|
+$17.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$153M |
| 2 |
O
OrbiMed
New York
|
-$51.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$44.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$40.9M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$37.2M |
IMMU Hedge Fund Activity: Q2 2019 in Review
204 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2019, worth a combined $2.38B — down 29% from $3.37B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new IMMU positions and 26 closed out — a net gain of 3 holders — while 85 added to existing stakes and 51 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $49.4M. The largest seller was Fidelity Investments, cutting an estimated $153M.
- 204 institutional investors held Immunomedics Inc (IMMU) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $2.38B of Immunomedics Inc stock for Q2 2019, down 29% quarter-over-quarter.
- 29 funds opened new Immunomedics Inc positions in Q2 2019 and 26 closed out, a net change of +3 holders.
- The largest Immunomedics Inc buyer in Q2 2019 was Avoro Capital Advisors, an estimated $49.4M added.
- The largest Immunomedics Inc seller in Q2 2019 was Fidelity Investments, an estimated $153M sold.
Based on aggregated 13F filings for Q2 2019.